BioNexus Gene Lab Corp 8-K

What Happened
BioNexus Gene Lab Corp. (BGLC) filed a Form 8‑K on June 5, 2026 to furnish (not file) a press release dated May 29, 2026. The release highlights the Company’s participation in the China‑Malaysia Economic Cooperation Outlook Forum on May 21, 2026 in Kuala Lumpur and calls for Malaysia‑China biotechnology cooperation to move beyond trade into co‑development, with emphasis on precision healthcare, cross‑border commercialization and platform building.

Key Details

• The 8‑K was filed June 5, 2026 and furnishes Exhibit 99.1 (press release dated May 29, 2026).
• Forum participation: China‑Malaysia Economic Cooperation Outlook Forum, May 21, 2026, Kuala Lumpur, Malaysia.
• Press release topics: Malaysia‑China biotech cooperation, precision healthcare collaboration, cross‑border biotech commercialization, and platform‑building opportunities.
• The press release is furnished (not “filed”) and therefore is not subject to Section 18 liability or automatically incorporated by reference into other SEC filings.

Why It Matters
This is a strategic, non‑financial disclosure showing BGLC’s focus on international partnerships and commercialization pathways in biotechnology and precision healthcare. For investors, the filing signals the company’s intent to pursue or promote cross‑border collaboration and platform development in Southeast Asia/China markets; it does not report any financial results, transactions, or management changes.